We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why Investors Should Hold on to Verisk (VRSK) Stock
Read MoreHide Full Article
Verisk Analytics, Inc.’s (VRSK - Free Report) shares have had a decent run on the bourses over the past year, gaining 19.3% against a 4.3% loss of the industry.
Image Source: Zacks Investment Research
The company has an expected long-term earnings per share (three-to-five years) growth rate of 10.2%. Its earnings are expected to increase 10.6% in 2022 and 10.8% in 2023, year over year.
Factors That Auger Well
Verisk has a robust growth strategy that focuses on organic growth, product development and acquisitions.
Using advanced technologies to collect and analyze data, Verisk draws on unique data assets and deep domain expertise to provide predictive analytics and decision-support solutions integrated into customer workflows. The company’s specialized and in-depth knowledge in markets such as energy, insurance, financial services and risk management adds value to its analytics. A steady stream of first-to-market innovations and the ability to deeply integrate into customer workflows allow it to strengthen its client base over time.
Verisk has been consistently acquiring and investing in companies globally to expand data and analytics capabilities across industries. The recent acquisition of Opta will expand Verisk’s position in the Canadian market. Their combined domain expertise, advanced technology and unique data assets should help their diverse range of clients in the insurance industry, ranging from insurers, brokers and other financial services companies to governments and risk managers.
Some Risks
Verisk’s cash and cash equivalent balance of $280.3 million at the end of fourth-quarter 2021 was well below the long-term debt level of $2.3 billion. The cash level cannot even meet the short-term debt of $766.6 million.
FactSet has an expected earnings growth rate of around 15.1% for the current year. FactSet has a trailing four-quarter earnings surprise of 6.1%, on average.
FactSet’s shares have surged 36.9% in the past year. FDS has a long-term earnings growth of 10%. FDS carries a Zacks Rank #2 (Buy).
Cross Country Healthcare has an expected long-term earnings per share (three-to-five years) growth rate of 6.6%. Cross Country Healthcare has a trailing four-quarter earnings surprise of 41.5%, on average.
Cross Country Healthcare’s shares have surged 76% in the past year. CCRN sports a Zacks Rank #1.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
Here's Why Investors Should Hold on to Verisk (VRSK) Stock
Verisk Analytics, Inc.’s (VRSK - Free Report) shares have had a decent run on the bourses over the past year, gaining 19.3% against a 4.3% loss of the industry.
Image Source: Zacks Investment Research
The company has an expected long-term earnings per share (three-to-five years) growth rate of 10.2%. Its earnings are expected to increase 10.6% in 2022 and 10.8% in 2023, year over year.
Factors That Auger Well
Verisk has a robust growth strategy that focuses on organic growth, product development and acquisitions.
Using advanced technologies to collect and analyze data, Verisk draws on unique data assets and deep domain expertise to provide predictive analytics and decision-support solutions integrated into customer workflows. The company’s specialized and in-depth knowledge in markets such as energy, insurance, financial services and risk management adds value to its analytics. A steady stream of first-to-market innovations and the ability to deeply integrate into customer workflows allow it to strengthen its client base over time.
Verisk has been consistently acquiring and investing in companies globally to expand data and analytics capabilities across industries. The recent acquisition of Opta will expand Verisk’s position in the Canadian market. Their combined domain expertise, advanced technology and unique data assets should help their diverse range of clients in the insurance industry, ranging from insurers, brokers and other financial services companies to governments and risk managers.
Some Risks
Verisk’s cash and cash equivalent balance of $280.3 million at the end of fourth-quarter 2021 was well below the long-term debt level of $2.3 billion. The cash level cannot even meet the short-term debt of $766.6 million.
Zacks Rank and Stocks to Consider
Verisk currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some better-ranked stocks in the broader Zacks Business Services sector are FactSet Research Systems Inc. (FDS - Free Report) and Cross Country Healthcare, Inc. (CCRN - Free Report) .
FactSet has an expected earnings growth rate of around 15.1% for the current year. FactSet has a trailing four-quarter earnings surprise of 6.1%, on average.
FactSet’s shares have surged 36.9% in the past year. FDS has a long-term earnings growth of 10%. FDS carries a Zacks Rank #2 (Buy).
Cross Country Healthcare has an expected long-term earnings per share (three-to-five years) growth rate of 6.6%. Cross Country Healthcare has a trailing four-quarter earnings surprise of 41.5%, on average.
Cross Country Healthcare’s shares have surged 76% in the past year. CCRN sports a Zacks Rank #1.